Sodium Deposition in Soft Tissues of Patients with Kidney Disease
Haemodialysis ComplicationSodium (Na+) hemostasis is abnormal in CKD patients, and this element can be deposited in the skin, muscle, and skeleton - to cope with long term sodium loading. It is known that sodium stored in this non-osmotically active way, is profoundly inflammatory. Furthermore, inflammation has been associated with several uremic symptoms. The investigators will use novel Na+ MRI imaging to examine the Na+ deposition in the skin, muscle, and skeleton of five groups:1) chronic in-center hemodialysis patients, 2) chronic peritoneal dialysis patients, 3) adult and paediatric patients with CKD stage 1-5 and 4) heart failure patients with and without renal dysfunction 5) sex and age-matched healthy adult and paediatric controls. Additionally, they will investigate the association between sodium deposition in these tissues with uremic symptomatology and biochemical markers of metabolism.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
6 and up
Participation Criteria
Inclusion Criteria:
* Age greater than or equal to 6 years
* For patients on maintenance hemodialysis or peritoneal dialysis: more than 3 months duration of therapy
* For patients with CKD stage 1-5: CKD stage 1-5 and no indications to start dialysis
* For heart failure patients: with or without renal dysfunction
* For healthy controls: lack of kidney disease, heart failure, liver cirrhosis, and peripheral edema
For subsequent visits (must meet 1 of the below indicators):
* Change in dialysis prescription
* Change in renal replacement therapy modality
* Change in medication
* Parathyroidectomy
* Intervention added to or removed from dialysis (i.e. such as but not limited exercise, cooling, and ischemic preconditioning)
Exclusion Criteria:
* Pregnant, breastfeeding or intending pregnancy
* Unable to give consent or understand written information
* Contraindication to MRI study
Study Location
LHSC Regional Renal Care Program
LHSC Regional Renal Care ProgramLondon, Ontario
Canada
Contact Study Team
Jean Theberge, PhD
Guido Filler, MD
- Study Sponsored By
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Participants Required
- More Information
- Study ID:
NCT03004547